Skip to main content

Table 2 The complications and side effect occurred in the EUS-LA and US-LA groups

From: Treatment response and preliminary efficacy of hepatic tumour laser ablation under the guidance of percutaneous and endoscopic ultrasonography

 

US-LA (n = 100)

EUS-LA (n = 20)

p value

Side effect

5 (5.0%)

3 (15.0%)

0.102

 PONV

0 (0%)

2 (10.0%)

0.001

 Abdominal pain

4 (4.0%)

1 (5.0%)

0.838

 Post-ablation fever

1 (1.0%)

0 (0%)

1.000

Major complication

1 (1.0%)

0 (0%)

1.000

 Sub-capsular haemobilia

1 (1.0%)

0 (0%)

1.000

  1. PONV post-operative nausea and vomiting, EUS endoscopic ultrasonography, US ultrasonography; LA laser ablation
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us